+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Incyte Corporation - logo

Incyte's is a biopharmaceutical company building a pipeline of small molecule drugs for serious unmet medical needs primarily in the area of oncology. Incyte's corporate headquarters are located in Wilmington, Delaware.

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-users, Stage of Development, Type of Product, Type of Technique, Application Area and Key Geographical Regions - Product Thumbnail Image

Global Liquid Biopsy Market 2018-2035: Distribution by Application, Target Disease Indication, Type of Circulating Biomarker, Type of Sample, End-users, Stage of Development, Type of Product, Type of Technique, Application Area and Key Geographical Regions

  • Report
  • December 2023
  • 331 Pages
  • Global
From
Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Global Forecast 2025-2030 - Product Thumbnail Image

Leukemia Therapeutics Market by Type, Treatment Type, Molecule Type, Mode of Administration, Gender - Global Forecast 2025-2030

  • Report
  • October 2024
  • 186 Pages
  • Global
From
Colorectal Cancer Drugs Market Report 2025 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Africa, Middle East
From
Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Europe
From
Asia Pacific Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 82 Pages
  • Asia Pacific
From
North America Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Country and Growth Forecast, 2022 - 2028

  • Report
  • November 2022
  • 74 Pages
  • North America
From
Chronic Myelogenous Leukemia Treatment - Global Strategic Business Report - Product Thumbnail Image

Chronic Myelogenous Leukemia Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 345 Pages
  • Global
Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Muscle-invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 321 Pages
  • Global
Bladder Cancer Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Bladder Cancer Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 394 Pages
  • Global
Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hidradenitis Suppurativa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 106 Pages
  • Global
From
Intrahepatic Cholangiocarcinoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • February 2024
  • 251 Pages
  • Global
From
Hypereosinophilic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypereosinophilic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 66 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Myelodysplastic Syndrome - Pipeline Review, H1 2020 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1667 Pages
  • Global
From
Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 260 Pages
  • Global
From
Loading Indicator